CoChat

2017 update on the relationship between diabetes and colorectal cancer: epidemiology, potential molecular mechanisms and therapeutic implications

Open access
González, Nieves, Diabetes Cancer Connect Consortium, Prieto, Isabel, del Puerto-Nevado, Laura, Portal-Nuñez, Sergio, Ardura, Juan Antonio, Corton, Marta, Fernández-Fernández, Beatriz, Aguilera, Oscar, Gomez-Guerrero, Carmen, Mas, Sebastián, Moreno, Juan Antonio, Ruiz-Ortega, Marta, Sanz, Ana Belen, Sanchez-Niño, Maria Dolores, Rojo, Federico, Vivanco, Fernando, Esbrit, Pedro, Ayuso, Carmen, Alvarez-Llamas, Gloria, Egido, Jesús, García-Foncillas, Jesús, Ortiz, Alberto · 2017 · Oncotarget
Cited by 168

The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.

Abstract

// Nieves González 1,* , Isabel Prieto 2,* , Laura del Puerto-Nevado 3,* , Sergio Portal-Nuñez 4,* , Juan Antonio Ardura 4 , Marta Corton 5 , Beatriz Fernández-Fernández 6,7 , Oscar Aguilera 3 , Carmen Gomez-Guerrero 6 , Sebastián Mas 6 , Juan Antonio Moreno 6 , Marta Ruiz-Ortega 6 , Ana Belen Sanz 6,7 , Maria Dolores Sanchez-Niño 6,7 , Federico Rojo 8 , Fernando Vivanco 9 , Pedro Esbrit 4 , Carmen Ayuso 5 , Gloria Alvarez-Llamas 7,9 , Jesús Egido 1,6 , Jesús García-Foncillas 3 , Alberto Ortiz 6,7 and Diabetes Cancer Connect Consortium 10 1 Renal, Vascular and Diabetes Research Laboratory, IIS-Fundacion Jimenez Diaz-UAM, Spanish Biomedical Research Network in Diabetes and Associated Metabolic Disorders (CIBERDEM), Madrid, Spain 2 Radiation Oncology, Oncohealth Institute, IIS-Fundacion Jimenez Diaz-UAM, Madrid, Spain 3 Translational Oncology Division, Oncohealth Institute, IIS-Fundacion Jimenez Diaz-UAM, Madrid, Spain 4 Bone and Mineral Metabolism laboratory, IIS-Fundacion Jimenez Diaz-UAM, Madrid, Spain 5 Genetics, IIS-Fundacion Jimenez Diaz-UAM, Madrid, Spain 6 Nephrology, IIS-Fundacion Jimenez Diaz-UAM, Madrid, Spain 7 REDINREN, Madrid, Spain 8 Pathology, IIS-Fundacion Jimenez Diaz-UAM, Madrid, Spain 9 Immunology, IIS-Fundacion Jimenez Diaz-UAM, Madrid, Spain 10 Membership of the DiabetesCancerConnect Consortium is provided in the Acknowledgments * These authors have contributed equally to this work Correspondence to: Alberto Ortiz, email: // Keywords : hyperglycemia, inflammation, diabetic kidney disease, colon cancer, diabetes mellitus Received : September 07, 2016 Accepted : December 26, 2016 Published : January 03, 2017 Abstract Worldwide deaths from diabetes mellitus (DM) and colorectal cancer increased by 90% and 57%, respectively, over the past 20 years. The risk of colorectal cancer was estimated to be 27% higher in patients with type 2 DM than in non-diabetic controls. However, there are potential confounders, information from lower income countries is scarce, across the globe there is no correlation between DM prevalence and colorectal cancer incidence and the association has evolved over time, suggesting the impact of additional environmental factors. The clinical relevance of these associations depends on understanding the mechanism involved. Although evidence is limited, insulin use has been associated with increased and metformin with decreased incidence of colorectal cancer. In addition, colorectal cancer shares some cellular and molecular pathways with diabetes target organ damage, exemplified by diabetic kidney disease. These include epithelial cell injury, activation of inflammation and Wnt/β-catenin pathways and iron homeostasis defects, among others. Indeed, some drugs have undergone clinical trials for both cancer and diabetic kidney disease. Genome-wide association studies have identified diabetes-associated genes (e.g. TCF7L2 ) that may also contribute to colorectal cancer. We review the epidemiological evidence, potential pathophysiological mechanisms and therapeutic implications of the association between DM and colorectal cancer. Further studies should clarify the worldwide association between DM and colorectal cancer, strengthen the biological plausibility of a cause-and-effect relationship through characterization of the molecular pathways involved, search for specific molecular signatures of colorectal cancer under diabetic conditions, and eventually explore DM-specific strategies to prevent or treat colorectal cancer.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.14472

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 43 references

Cited by

Metadata

Authors
González, N., Diabetes Cancer Connect Consortium, Prieto, I., del Puerto-Nevado, L., Portal-Nuñez, S., Ardura, J. A., Corton, M., Fernández-Fernández, B., Aguilera, O., Gomez-Guerrero, C., Mas, S., Moreno, J. A., Ruiz-Ortega, M., Sanz, A. B., Sanchez-Niño, M. D., Rojo, F., Vivanco, F., Esbrit, P., Ayuso, C., Alvarez-Llamas, G., Egido, J., García-Foncillas, J., & Ortiz, A.
Venue
Oncotarget
Published
2017-01-03
Volume
8
Issue
11
Pages
18456-18485
ISSN
1949-2553 (ISSN-L)
OpenAlex
W2568726620
Cited by
168
References
43
FWCI
6.70
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.